- Home
- ANY vs ADAP Comparison
ANY vs ADAP Comparison
Compare ANY & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANY
- ADAP
- Stock Information
- Founded
- ANY N/A
- ADAP 2008
- Country
- ANY United States
- ADAP United Kingdom
- Employees
- ANY N/A
- ADAP N/A
- Industry
- ANY Finance: Consumer Services
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- ANY Finance
- ADAP Health Care
- Exchange
- ANY Nasdaq
- ADAP Nasdaq
- Market Cap
- ANY 23.8M
- ADAP 21.3M
- IPO Year
- ANY N/A
- ADAP 2015
- Fundamental
- Price
- ANY $0.88
- ADAP $0.19
- Analyst Decision
- ANY Strong Buy
- ADAP Hold
- Analyst Count
- ANY 1
- ADAP 6
- Target Price
- ANY $3.00
- ADAP $1.02
- AVG Volume (30 Days)
- ANY 688.9K
- ADAP 177.4M
- Earning Date
- ANY 11-13-2025
- ADAP 11-12-2025
- Dividend Yield
- ANY N/A
- ADAP N/A
- EPS Growth
- ANY N/A
- ADAP N/A
- EPS
- ANY N/A
- ADAP N/A
- Revenue
- ANY $10,831,000.00
- ADAP $65,084,999.00
- Revenue This Year
- ANY N/A
- ADAP N/A
- Revenue Next Year
- ANY $36.07
- ADAP $24.70
- P/E Ratio
- ANY N/A
- ADAP N/A
- Revenue Growth
- ANY N/A
- ADAP N/A
- 52 Week Low
- ANY $0.36
- ADAP $0.04
- 52 Week High
- ANY $1.90
- ADAP $0.91
- Technical
- Relative Strength Index (RSI)
- ANY 65.56
- ADAP 62.98
- Support Level
- ANY $0.83
- ADAP $0.12
- Resistance Level
- ANY $0.92
- ADAP $0.27
- Average True Range (ATR)
- ANY 0.07
- ADAP 0.03
- MACD
- ANY 0.01
- ADAP 0.01
- Stochastic Oscillator
- ANY 58.79
- ADAP 50.48
About ANY Sphere 3D Corp.
Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.